Massive Bio Featured in Two Categories on CB Insights’ AI Drug R&D Market Map
Massive Bio, one of the leaders in AI-powered oncology patient recruitment and clinical trial matching, has been named in two pivotal categories on CB Insights’ latest AI Drug Research & Development Market Map. This recognition underscores Massive Bio’s innovative contributions to revolutionising cancer care through advanced artificial intelligence solutions. CB Insights’ market map highlights companies […]
Feinstein Institutes Researchers Demonstrate Successful Study of Lupus Kidney Disease
Researchers at Northwell Health’s Feinstein Institutes for Medical Research found that obinutuzumab, a therapeutic antibody that depletes B cells and is approved for the treatment of B cell malignancies, benefitted patients with lupus nephritis, a severe complication of lupus that compromises kidney function. The study, which was led by Richard A. Furie, MD, professor in the Feinstein Institutes’ Institute of […]
Quit Smoking Efforts Aim to Combat Cancer Risks Worldwide
Cigarette smoking is the primary cause of major health concerns such as cancer. According to the World Health Organization, the use of tobacco accounts for 25% of all cancer deaths around the globe. The National Institutes of Health notes that inhaling dangerous chemicals and carcinogens found in cigarettes can damage a cell’s DNA and lead […]
